Torben Straight Nissen, President at Rubius Therapeutics, Inc. (RUBY), sold 2,100 shares at $20.00 ($42K) on 2019-04-08, disclosed to the SEC on 2019-04-10.
Scheduled sale ($42k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.